石药集团CEO换人，蔡磊获委任为副主席及执行董事等职

CPHI制药在线12-20

编辑 | 晓琳来源 | 赛柏蓝12月19日，石药集团有限公司（以下简称“石药集团”）官网发布重磅人事变动公告，对执行董事、副主席、首席执行官、首席运营官等多个核心岗位进行调整。公告显示，为石药集团服务多年的“老将”张翠龙因工作调动，卸任董事会副主席、首席执行官及授权代表职务，但仍将留任执行董事。接棒者是备受瞩目的蔡磊，其被委任为执行董事、副主席、首席执行官及授权代表。同时，魏青杰也获委任为执行董事...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2592110481?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-20 15:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2592110481","market":"hk","top_or_hot":-1,"title":"石药集团CEO换人，蔡磊获委任为副主席及执行董事等职","media":"CPHI制药在线","content":"<div>\n<p>编辑 | 晓琳来源 | 赛柏蓝12月19日，石药集团有限公司（以下简称“石药集团”）官网发布重磅人事变动公告，对执行董事、副主席、首席执行官、首席运营官等多个核心岗位进行调整。公告显示，为石药集团服务多年的“老将”张翠龙因工作调动，卸任董事会副主席、首席执行官及授权代表职务，但仍将留任执行董事。接棒者是备受瞩目的蔡磊，其被委任为执行董事、副主席、首席执行官及授权代表。同时，魏青杰也获委任为执行董事...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>石药集团CEO换人，蔡磊获委任为副主席及执行董事等职</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n石药集团CEO换人，蔡磊获委任为副主席及执行董事等职\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-20 15:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b><strong>CPHI制药在线</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>编辑 | 晓琳来源 | 赛柏蓝12月19日，石药集团有限公司（以下简称“石药集团”）官网发布重磅人事变动公告，对执行董事、副主席、首席执行官、首席运营官等多个核心岗位进行调整。公告显示，为石药集团服务多年的“老将”张翠龙因工作调动，卸任董事会副主席、首席执行官及授权代表职务，但仍将留任执行董事。接棒者是备受瞩目的蔡磊，其被委任为执行董事、副主席、首席执行官及授权代表。同时，魏青杰也获委任为执行董事...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1226287875.USD","symbol_name":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"PM\" (USD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b","article_id":"2592110481","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592110481","pubTimestamp":1766215851,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"公告显示，为石药集团服务多年的“老将”张翠龙因工作调动，卸任董事会副主席、首席执行官及授权代表职务，但仍将留任执行董事。此次卸任的CEO张翠龙自1996年加入石药集团，并于2018年获委任为执行董事；2019年担任副主席、轮值行政总裁；2022年委任为行政总裁，一路见证了石药集团的重要发展阶段。新任CEO蔡磊则是石药集团董事会主席、执行董事及主要股东蔡东晨之子，也是执行董事蔡鑫的胞兄。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1226287875.USD":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"PM\" (USD) INC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","01093":"石药集团","BK1191":"制药","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","IE00B031HY20.USD":"FSSA CHINA GROWTH \"I\" (USD) INC","LU1226288253.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) INC","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","BK1515":"抗疫概念","LU1951186391.HKD":"UBS (LUX) KEY SEL CHINA ALLOCATION OPPORTUNITY (US \"P\" (HKD) INC","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","IE0008369823.USD":"FSSA HONG KONG GROWTH \"I\" ACC","LU1813983027.USD":"MANULIFE GF DRAGON GROWTH \"AA\" (USD) INC","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","LU1993786604.SGD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (SGD) ACC","LU1960683339.HKD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (HKD) ACC","LU1226287792.SGD":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"P\" (SGDHDG) INC","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","LU0140636845.USD":"施罗德大中华区股票A Acc","BK1521":"挪威政府全球养老基金持仓","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","LU1328277881.USD":"MANULIFE GF DRAGON GROWTH FUND \"AA\" (USD) INC","LU1152091754.HKD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" (HKD) INC","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","LU0314109678.HKD":"MANULIFE GF DRAGON GROWTH \"AA\" (HKD) INC","LU1008478684.HKD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (HKD) ACC","IE0008368742.USD":"首域中国增长基金I Acc","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU1226288170.HKD":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"P6%\"(HK D) INC"},"translate_title":"CSPC CEO replacement, Cai Lei appointed as vice chairman and executive director","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1.5},"content_text":"编辑 | 晓琳来源 | 赛柏蓝12月19日，石药集团有限公司（以下简称“石药集团”）官网发布重磅人事变动公告，对执行董事、副主席、首席执行官、首席运营官等多个核心岗位进行调整。公告显示，为石药集团服务多年的“老将”张翠龙因工作调动，卸任董事会副主席、首席执行官及授权代表职务，但仍将留任执行董事。接棒者是备受瞩目的蔡磊，其被委任为执行董事、副主席、首席执行官及授权代表。同时，魏青杰也获委任为执行董事、副主席及首席运营官，构成新的核心管理团队。此次卸任的CEO张翠龙自1996年加入石药集团，并于2018年获委任为执行董事；2019年担任副主席、轮值行政总裁；2022年委任为行政总裁，一路见证了石药集团的重要发展阶段。新任CEO蔡磊则是石药集团董事会主席、执行董事及主要股东蔡东晨之子，也是执行董事蔡鑫的胞兄。现年45岁的蔡磊拥有北京师范大学生物化学学士及新加坡国立大学博士学位，2014年4月加入石药集团 ，其现任执行总裁、美国研发事业部副总裁及医药产品销售事业部总裁，主要负责石药集团海外研发及销售相关业务 。根据公告，其薪酬为每月1.7万美元，另加每年6.3万港元的董事袍金。此次高层人事调整，正值石药集团关键的转型节点。2025年前三季度，石药集团总收入为198.91亿元，同比下滑12.3%；股东应占溢利35.11亿元，同比减少7.1%。业绩下滑主要受核心的成药业务拖累，该板块营收154.5亿元，同比下降17.2%。其中，曾作为增长动力的抗肿瘤药物收入跌幅最为显著，同比减少56.8%至16.45亿元。而营收最高的神经系统领域（56.69亿元），也同比下滑了21.6%。石药集团不断加码创新。2025年上半年，其研发费用比增加5.5%至26.83亿元。有近90个产品在临床试验的不同阶段，其中12个已递交上市申请，超过30个重点产品处于注册临床阶段。预计到2028年底，将有50余款新药或新适应症申报上市。此外，12月10日，石药创新在港交所递交招股书，开始了其港股上市的新篇章。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592110481","isCrawlerRequest":true}